Robert David Thomas sold $6.7M of IBM
Senior Vice President at INTERNATIONAL BUSINESS MACHINES CORP. 26,543 shares at an average of $253.01, traded Mar 3, 2025, filed Mar 3, 2025.
Score components
- +15RoleOfficer
- +25Trade size$6.7M at market
- +10Share of holdings soldSold 37% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001562180-25-001867, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 3, 2025 | SOpen-market sale Common Stock | -26,543 | $253.01 | $6.7M | 45,007 | Mar 3, 2025 |
Related signals
Other insiders at INTERNATIONAL BUSINESS MACHINES CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 32Weak | IBMbuy INTERNATIONAL BUSINESS MACHINES CORP | David N Farr director | $299k 1,200 shares | +17% | |
| 35Weak | IBMbuy INTERNATIONAL BUSINESS MACHINES CORP | Alfred W Zollar director | $197k 936 shares | - | |
| 42Moderate | IBMsell INTERNATIONAL BUSINESS MACHINES CORP | Nickle Jaclyn Lamoreaux Senior Vice President | $775k 3,600 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.